Rand Capital (RAND) Q2 FY26 earnings call: guidance

Earnings call· Jun 2026 (Q2 FY26)· Financials· Aug 5, 2026

Source: earnings call transcript

Executive summary

Rand Capital Q2 FY26 — Portfolio Growth Amidst Non-Accrual Headwinds

Rand Capital navigated Q2 FY26 with a dual focus on portfolio expansion and active management of challenged assets. The company successfully deployed $6.9 million into new income-producing investments and realized a gain from an exit, contributing to an increase in net asset value per share. However, earnings continued to be pressured by non-accruals and a significant write-down, impacting overall investment income and portfolio yield. Management emphasized a disciplined approach to capital allocation and portfolio rebuilding to support future earnings and shareholder returns.

Highlights

Accelerated deployment into new income-producing investments, totaling $6.9 million in Q2 FY26.
Realized a gain of $959,000 on the exit of Applied Image in Q2 FY26.
Net asset value increased to $17.33 per share at quarter-end, up from the prior quarter.
Maintained regular quarterly dividend of $0.29 per share for Q2 and declared for Q3 FY26.

Concerns

Total investment income declined to $1.4 million in Q2 FY26 from $1.6 million in prior year, primarily due to portfolio non-accruals.
Net investment income decreased to $0.24 per share in Q2 FY26 from $0.83 per share in Q2 FY25.
Full write-down of B&P Swanson resulted in a $2.5 million quarter-over-quarter fair value decline.
Annualized weighted average yield on debt investments decreased to 8.98% at Q2 FY26 from 11.3% at year-end 2025 due to non-accruals.

Guidance & targets

Category	Target	Timeline	Confidence
Quarterly Dividend	$0.29 per share medium materiality	Q3 · FY26	High

Deals & partnerships

Feature Healthcare (Four Seasons Home Care) New investment consisting of a term loan $4.5 million

Investment fits within strategy of financing lower middle market companies in attractive sectors.

Termite Guy Corporation New investment consisting of a term loan and equity $2.4 million

Partnered with a past deal sponsor (RAC Group/Cybirds) for this investment, combining current income with long-term equity upside.

Applied Image Full repayment of debt investment and realized gain on warrants $1.7 million debt repayment; $959,000 realized gain

Received full repayment of its debt investment.

Another debt investment Debt repayment $250,000

Further reflects the capital recycling dynamic embedded in the model.

B&P Swanson Full write-down due to cessation of operations

An unexpected and disappointing outcome, demonstrating the challenging economic environment.

Risks & headwinds

Portfolio non-accruals Ongoing

Weighing on interest income and reported yield; annualized weighted average yield on debt investments decreased to 8.98% from 11.3%.

Mitigation:Actively managing challenged positions and adding new performing assets.

Challenging economic and business environment Ongoing

Full write-down of B&P Swanson resulted in a $2.5 million quarter-over-quarter fair value decline.

Mitigation:Disciplined portfolio management, focusing on credit quality, structure, and overall portfolio construction.

Competitive private credit market Ongoing

Market remains competitive and at times uneven.

Mitigation:Emphasizing experience, selectivity, and portfolio discipline in capital allocation.

What to watch in Q3 FY26

Portfolio Building Pace

Balance of 2026

Current $6.9 million invested in Q2 FY26

Target Continued deployment into new income-producing investments

Why it matters

Demonstrates execution on growth strategy and ability to offset non-accruals.

We want to continue building the portfolio. We are seeing origination opportunities in the lower middle market. And we intend to pursue them with a measured approach that keeps underwriting, structure, and risk-adjusted return both front and center.

Find out whether RAND delivers this. Inve re-checks your case every morning.

2 min read 5 chapters

Detailed narrative

Portfolio Strategy and Mix

The portfolio at June 30 had a fair value of $56.5 million across 21 companies, up from $48.5 million at year-end 2025. It remains primarily debt-oriented with 79% invested in debt and 21% in equity at fair value, reflecting an emphasis on current income while preserving selective upside. Management believes this predominantly debt-orientated portfolio is the right positioning for rebuilding earning assets and managing through a mixed market backdrop.

Investment Activity Highlights

During Q2 FY26, Rand Capital invested $6.9 million into two new portfolio companies: Feature Healthcare (doing business as Four Seasons Home Care) with a $4.5 million term loan carrying 12% cash interest plus 2% PIK, and Termite Guy Corporation with a $2.4 million investment consisting of a $2.1 million term loan at 13% plus 1% PIK and a $300,000 equity investment. The company also received full repayment of its $1.7 million debt investment in Applied Image, recognizing a $959,000 realized gain on warrants, and a $250,000 repayment on another debt investment.

Impact of Non-Accruals and Write-downs

The annualized weighted average yield on debt investments, including PIK interest, was 8.98% at quarter-end, a decline from 11.3% at December 31, 2025, primarily due to portfolio non-accruals. The full write-down of B&P Swanson, which ceased operations, resulted in a $2.5 million quarter-over-quarter fair value decline. This event demonstrates the ongoing challenging economic and business environment and the potential for volatility in portfolio businesses.

Shareholder Returns and Dividend Policy

Rand Capital paid its regular quarterly dividend of $0.29 per share for Q2 FY26 and declared the same for Q3 FY26. Management is focused on supporting the dividend through recurring income, liquidity management, and steady portfolio rebuilding over time. The approach balances current shareholder returns with long-term portfolio development, identifying new investments, and supporting the current portfolio where appropriate.

Portfolio Composition and Concentration

The portfolio's industry exposure remains balanced, with professional and business services as the largest area, followed by health and wellness, distribution, manufacturing, and consumer-related investments. The top five investments represented $24.1 million of fair value, or 43% of the portfolio at June 30, including IMEA, Kitech, Future Healthcare, Highlands All About People, and BNP Food Service Supply. The objective is to preserve value in these larger positions while building additional income-producing assets.

Summary of the company's earnings call; see how call summaries are prepared. Not investment advice.